251 related articles for article (PubMed ID: 17437420)
21. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population.
Fukami A; Adachi H; Yamagishi S; Matsui T; Ueda S; Nakamura K; Enomoto M; Otsuka M; Kumagae S; Nanjo Y; Kumagai E; Esaki E; Murayama K; Hirai Y; Imaizumi T
Metabolism; 2009 Dec; 58(12):1688-93. PubMed ID: 19616266
[TBL] [Abstract][Full Text] [Related]
22. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
23. The common allergens in the Churg-Strauss syndrome.
Bottero P; Bonini M; Vecchio F; Grittini A; Patruno GM; Colombo B; Sinico RA
Allergy; 2007 Nov; 62(11):1288-94. PubMed ID: 17919144
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box chromosomal protein 1 in patients with renal diseases.
Sato F; Maruyama S; Hayashi H; Sakamoto I; Yamada S; Uchimura T; Morita Y; Ito Y; Yuzawa Y; Maruyama I; Matsuo S
Nephron Clin Pract; 2008; 108(3):c194-201. PubMed ID: 18311084
[TBL] [Abstract][Full Text] [Related]
25. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature.
Agard C; Rendu E; Leguern V; Ponge T; Masseau A; Barrier JH; Trochu JN; Hamidou MA; Guillevin L
Semin Arthritis Rheum; 2007 Jun; 36(6):386-91. PubMed ID: 17303217
[TBL] [Abstract][Full Text] [Related]
26. Multiple tracheobronchial mucosal lesions in two cases of Churg-Strauss syndrome.
Matsushima H; Takayanagi N; Kurashima K; Tokunaga D; Ubukata M; Kawabata Y; Sugita Y
Respirology; 2006 Jan; 11(1):109-12. PubMed ID: 16423211
[TBL] [Abstract][Full Text] [Related]
27. [Serum level of HMGB1 in patients with hepatitis B and its clinical significance].
Liu HB; Fan XG; Huang JJ; Li N; Peng JP; Li SL; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):812-5. PubMed ID: 18073062
[TBL] [Abstract][Full Text] [Related]
28. Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid.
Taki H; Shinoda K; Hounoki H; Ogawa R; Ishizawa S; Sugiyama E; Tobe K
Scand J Rheumatol; 2010 Aug; 39(4):341-3. PubMed ID: 20560805
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the diagnosis of Churg-Strauss syndrome.
Churg A
Mod Pathol; 2001 Dec; 14(12):1284-93. PubMed ID: 11743052
[TBL] [Abstract][Full Text] [Related]
30. [The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].
Szczeklik W; Sokołowska BM; Mastalerz L; Górka J; Pacułt K; Soja J; Musiał J
Przegl Lek; 2010; 67(7):439-42. PubMed ID: 21387750
[TBL] [Abstract][Full Text] [Related]
31. Churg-Strauss vasculitis in a patient treated with omalizumab.
Bargagli E; Madioni C; Olivieri C; Penza F; Rottoli P
J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
[TBL] [Abstract][Full Text] [Related]
32. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
33. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
34. [Churg-Strauss syndrome].
Garini G; Corradi D; Vaglio A; Buzio C
Recenti Prog Med; 2003 Dec; 94(12):573-81. PubMed ID: 14974155
[TBL] [Abstract][Full Text] [Related]
35. Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome.
Mitsuyama H; Matsuyama W; Iwakawa J; Higashimoto I; Watanabe M; Osame M; Arimura K
Chest; 2006 Feb; 129(2):407-411. PubMed ID: 16478859
[TBL] [Abstract][Full Text] [Related]
36. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
Kohno T; Anzai T; Naito K; Miyasho T; Okamoto M; Yokota H; Yamada S; Maekawa Y; Takahashi T; Yoshikawa T; Ishizaka A; Ogawa S
Cardiovasc Res; 2009 Feb; 81(3):565-73. PubMed ID: 18984601
[TBL] [Abstract][Full Text] [Related]
37. Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo.
Suda K; Takeuchi H; Hagiwara T; Miyasho T; Yamada S; Inoue T; Okamoto M; Wada N; Saikawa Y; Fukunaga K; Hashimoto S; Yokota H; Maruyama I; Kitagawa Y
ASAIO J; 2010; 56(3):210-4. PubMed ID: 20335795
[TBL] [Abstract][Full Text] [Related]
38. High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis of falciparum malaria.
Alleva LM; Yang H; Tracey KJ; Clark IA
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):171-4. PubMed ID: 15653118
[TBL] [Abstract][Full Text] [Related]
39. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
[TBL] [Abstract][Full Text] [Related]
40. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.
Cottin V; Khouatra C; Dubost R; Glérant JC; Cordier JF
Allergy; 2009 Apr; 64(4):589-95. PubMed ID: 19154547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
